Judge Says Zicam Investor Suit May Proceed

A decision to allow investor lawsuits against Matrixx Initiatives, Inc. has been upheld by the Supreme Court. The high court’s decision upholds the 9th US Circuit Court of Appeal’s decision overturning a lower court ruling that threw out the lawsuits involving Zicam nasal cold remedies. The investors have argued in their lawsuits that they should have been told that the Zicam product might cause users to lose their sense of smell.
The original court had ruled to dismiss the lawsuits because there was no statistical proof linking anosmia (loss of smell) to the Zicam product.